164 research outputs found
Alien Registration- Bass, Frederick G. (Portland, Cumberland County)
https://digitalmaine.com/alien_docs/24093/thumbnail.jp
Morality in combat.
The factors that contribute to a military officer's moral and ethical decisions in combat are investigated with a qualitative study of interviews conducted with thirteen veterans. Theories of moral reasoning are discussed from philosophical and psychological standpoints and are then applied to the interview format. Data are then analyzed for patterns and these patterns are linked with those drawn from military and psychological literature. Three patterns demonstrate an officer's need for control over his environment, the responsibility he feels towards his men, and how the officer must live with his decisions post hoc
Access to Justice for a New Century: The Way Forward
This book is a timely addition to the literature on access to justice. The book\u27s essays address all aspects of the topic, including differing views on the meaning of access to justice; ways to improve access to legal services; litigation and its role in achieving social justice; and the roles of lawyers, citizens, and legal insitutions.
Access to Justice for a New Century is based on papers given at an international symposium presented by the Law Society of Upper Canada, sponsored by the Law Foundation of Ontario.https://digitalcommons.osgoode.yorku.ca/faculty_books/1095/thumbnail.jp
Rifaximin Treatment in Hepatic Encephalopathy
Background
Hepatic encephalopathy is a chronically debilitating complication of hepatic cirrhosis. The efficacy of rifaximin, a minimally absorbed antibiotic, is well documented in the treatment of acute hepatic encephalopathy, but its efficacy for prevention of the disease has not been established.
Methods
In this randomized, double-blind, placebo-controlled trial, we randomly assigned 299 patients who were in remission from recurrent hepatic encephalopathy resulting from chronic liver disease to receive either rifaximin, at a dose of 550 mg twice daily (140 patients), or placebo (159 patients) for 6 months. The primary efficacy end point was the time to the first breakthrough episode of hepatic encephalopathy. The key secondary end point was the time to the first hospitalization involving hepatic encephalopathy.
Results
Rifaximin significantly reduced the risk of an episode of hepatic encephalopathy, as compared with placebo, over a 6-month period (hazard ratio with rifaximin, 0.42; 95% confidence interval [CI], 0.28 to 0.64; P
Conclusions
Over a 6-month period, treatment with rifaximin maintained remission from hepatic encephalopathy more effectively than did placebo. Rifaximin treatment also significantly reduced the risk of hospitalization involving hepatic encephalopathy. (ClinicalTrials.gov number, NCT00298038.
Childhood in Sociology and Society: The US Perspective
The field of childhood studies in the US is comprised of cross-disciplinary researchers who theorize and conduct research on both children and youth. US sociologists who study childhood largely draw on the childhood literature published in English. This article focuses on American sociological contributions, but notes relevant contributions from non-American scholars published in English that have shaped and fueled American research. This article also profiles the institutional support of childhood research in the US, specifically outlining the activities of the ‘Children and Youth’ Section of the American Sociological Association (ASA), and assesses the contributions of this area of study for sociology as well as the implications for an interdisciplinary field.Yeshttps://us.sagepub.com/en-us/nam/manuscript-submission-guideline
Reference Ranges for the Clinical Laboratory Derived from a Rural Population in Kericho, Kenya
The conduct of Phase I/II HIV vaccine trials internationally necessitates the development of region-specific clinical reference ranges for trial enrolment and participant monitoring. A population based cohort of adults in Kericho, Kenya, a potential vaccine trial site, allowed development of clinical laboratory reference ranges. Lymphocyte immunophenotyping was performed on 1293 HIV seronegative study participants. Hematology and clinical chemistry were performed on up to 1541 cohort enrollees. The ratio of males to females was 1.9∶1. Means, medians and 95% reference ranges were calculated and compared with those from other nations. The median CD4+ T cell count for the group was 810 cells/µl. There were significant gender differences for both red and white blood cell parameters. Kenyan subjects had lower median hemoglobin concentrations (9.5 g/dL; range 6.7–11.1) and neutrophil counts (1850 cells/µl; range 914–4715) compared to North Americans. Kenyan clinical chemistry reference ranges were comparable to those from the USA, with the exception of the upper limits for bilirubin and blood urea nitrogen, which were 2.3-fold higher and 1.5-fold lower, respectively. This study is the first to assess clinical reference ranges for a highland community in Kenya and highlights the need to define clinical laboratory ranges from the national community not only for clinical research but also care and treatment
The impact of changes in stakeholder salience on CSR activities in Russian energy firms: a contribution to the divergence / convergence debate
This empirical paper examines the drivers underpinning changes to socially-responsible behaviours in the Russian energy sector. Responding to recent requests to contextualise CSR research, we focus on the changing set of stakeholders and developments in their saliency as reflected in corporations’ CSR activities. Based on interviews with more than thirty industry professionals, our findings suggest that Russian energy companies’ CSR is strongly stakeholder driven, and organisations adapt their activities according to their dependence on the resources that these salient stakeholders possess.
We challenge the proposition that CSR in Russia arises from purely endogenous, historical, paternalism or neo-paternalism. We identify stakeholders that now shape CSR in the Russian energy sector, both endogenous (institutional and contextual forces relevant to the national business system) and exogenous (relating to the organisational field of the energy industry - international by nature). We thereby contribute to the convergence / divergence debate within CSR theory by demonstrating that both national business systems and the organisational field must be taken into account when analysing the forces that shape CSR strategies in any one country
The source of hydrogen sulfide in anoxic sediment
Putrefactive hydrogen sulfide production in the upper 4 cm of sediment in two small freshwater and eutrophic Southeast Michigan, U.S.A., lakes ranged from 0.13 to 1.51 with an average of 0.46 mg S l-1 day-1. Sulfate reductive production of hydrogen sulfide at the same sites ranged from 0.7 to 3.2 with an average of 1.54 mg S l-1 day-1. Putrefactive hydrogen sulfide production represented 5.1-53% (average of 18.3-27.6%) of the total hydrogen sulfide produced at the two lakes over an April-October study period. 35S labeled substrates were used to estimate hydrogen sulfide production rates.Proteolytic bacteria averaged 2.2 x 104 cells ml-1 sediment whereas sulfate reducers averaged 4.8 x 102 cells ml-1 sediment. Putrefactive hydrogen sulfide production correlated highly with numbers of proteolytic bacteria (r2 = 0.84) but the correlation between sulfate reduction and sulfate reducing bacteria was low (r2 = 0.13).Interstitial soluble inorganic sulfate, protein and organic carbon were not closely correlated with hydrogen sulfide production rates or bacteria enumeration results. Natural substrate concentrations (Sn) used to estimate hydrogen sulfide production were supported by kinetic bioassay results.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/25926/1/0000489.pd
BMQ
BMQ: Boston Medical Quarterly was published from 1950-1966 by the Boston University School of Medicine and the Massachusetts Memorial Hospitals
Resilience to loss and chronic grief: A prospective study from preloss to 18-months postloss.
- …